Milestone Pharmaceuticals Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Milestone Pharmaceuticals Inc. (MIST) had Lessee, Operating Lease, Liability, to be Paid, Year One of $709.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-20.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-03-20
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $709.00K.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $658.00K.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $673.00K.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $657.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $709.00K 10-K · filed 2026-03-20 |
| 2024-12-31 | $658.00K 10-K · filed 2025-03-13 |
| 2023-12-31 | $673.00K 10-K · filed 2024-03-21 |
| 2022-12-31 | $657.00K 10-K · filed 2023-03-29 |
| 2021-12-31 | $243.00K 10-K · filed 2022-03-24 |
| 2019-12-31 | $354.00K 10-K/A · filed 2020-10-23 |
| 2019-09-30 | $389.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $187.00K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $183.00K 10-Q · filed 2019-06-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |